Longchen Wang

Shanghai Jiao Tong University

Papers

3

Total Citations

155

H-Index

3

About

Dr. Longchen Wang is a pioneering researcher at the intersection of nanorobotics, targeted drug delivery, and interventional medicine, whose work is redefining the treatment of vascular and infectious diseases. His primary research focuses on developing magnetically actuated micro/nanorobots to overcome critical biological barriers, such as interrupted blood flow in thrombolysis and biofilm resistance in infections. Dr. Wang’s major contributions include the design of a C-shaped magnetic actuation system that dramatically enhances the delivery of tissue plasminogen activator (tPA) for potentiated thrombolysis, achieving rapid clot dissolution even in compromised vasculature (68 citations). He also pioneered an electromagnetically actuated magneto-nanozyme platform that synergistically destroys and eradicates bacterial biofilms, addressing a major challenge in chronic infections (50 citations). His work on enzyme-magnetite nanoparticle swarms demonstrates a pharmacomechanical approach for low-dose, fast thrombolysis, showcasing his ability to integrate therapeutic and mechanical functions (37 citations). With over 150 combined citations, Dr. Wang’s innovations are paving the way for next-generation, minimally invasive treatments that are safer, more effective, and precisely controllable.

Research Focus

Key Achievements

3
H-Index
3
Papers
155
Total Citations
52
Avg Citations/Paper
🏆 Most Cited Paper
Guiding Drug Through Interrupted Bloodstream for Potentiated Thrombolysis by C‐Shaped Magnetic Actuation System In Vivo
68 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 28
🏛 Institutions: Shanghai Jiao Tong University

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago